Risdiplam Compassionate Use Program Group[Corporate Author] - Search Results

Save citations to file

Your saved search

Your RSS Feed

Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany.

Hahn A, Günther R, Ludolph A, Schwartz O, Trollmann R, Weydt P, Weiler M, Neuland K, Schwaderer MS, Hagenacker T; Risdiplam Compassionate Use Program Group. Hahn A, et al. Orphanet J Rare Dis. 2022 Jul 19;17(1):276. doi: 10.1186/s13023-022-02420-8. Orphanet J Rare Dis. 2022. PMID: 35854272 Free PMC article.

Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany.

Hahn A, Günther R, Ludolph A, Schwartz O, Trollmann R, Weydt P, Weiler M, Neuland K, Schwaderer MS, Hagenacker T; Risdiplam Compassionate Use Program Group. Hahn A, et al. Orphanet J Rare Dis. 2022 Oct 25;17(1):387. doi: 10.1186/s13023-022-02548-7. Orphanet J Rare Dis. 2022. PMID: 36284315 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters